首页> 美国卫生研究院文献>BMJ Open Diabetes Research Care >Efficacy and safety of linagliptin in Hispanic/Latino patients with type 2 diabetes mellitus: a pooled analysis from six randomized placebo-controlled phase 3 trials

【2h】

Efficacy and safety of linagliptin in Hispanic/Latino patients with type 2 diabetes mellitus: a pooled analysis from six randomized placebo-controlled phase 3 trials

机译：拉格列汀在西班牙裔/拉丁美洲裔2型糖尿病患者中的疗效和安全性：六项随机安慰剂对照的3期临床试验的汇总分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

ObjectiveThe number of individuals diagnosed with type 2 diabetes mellitus is expected to rise disproportionately in Hispanic/Latino populations. We therefore aimed to assess the efficacy and safety of the dipeptidyl peptidase-4 inhibitor linagliptin specifically in Hispanic/Latino patients with type 2 diabetes mellitus.

机译：目的在西班牙裔/拉丁美洲裔人群中，被诊断出患有2型糖尿病的人数有望不成比例地增加。因此，我们旨在评估二肽基肽酶-4抑制剂利格列汀在2型糖尿病的西班牙裔/拉丁美洲裔患者中的疗效和安全性。

著录项

期刊名称 BMJ Open Diabetes Research Care
作者
Jaime A Davidson; Rosemarie Lajara; Richard B Aguilar; Michaela Mattheus; Hans-Juergen Woerle; Maximilian von Eynatten;
展开▼
作者单位

展开▼
年(卷),期 2014(2),1
年度 2014
页码 e000020
总页数 9
原文格式 PDF
正文语种
中图分类心血管疾病;
关键词
A1C Hispanic Clinical Trial(s) Endocrinology Diabetes;

机译：A1C;西班牙裔;临床试验;内分泌糖尿病;

相似文献

外文文献
中文文献
专利

1. Efficacy and safety of linagliptin in Hispanic/Latino patients with type 2 diabetes mellitus: a pooled analysis from six randomized placebo-controlled phase 3 trials [J] . Hans-Juergen Woerle, Jaime A Davidson, Maximilian von Eynatten, BMJ Open Diabetes Research & Care . 2014,第1期

机译：拉格列汀在西班牙裔/拉丁美洲裔2型糖尿病患者中的功效和安全性：六项随机安慰剂对照的3期临床试验的汇总分析
2. Efficacy and Safety of Sitagliptin in Hispanic/Latino Patients with Type 2 Diabetes: A Pooled Analysis from Ten Randomized, Placebo-Controlled Phase 3 Clinical Trials [J] . Annaswamy Raji, Jianmin Long, Raymond L. H. Lam, Diabetes therapy . 2018,第4期

机译：西他列汀在西班牙裔/拉丁裔2型糖尿病患者中的功效和安全性：十项随机，安慰剂对照的3期临床试验的汇总分析
3. Efficacy and Safety of Linagliptin in Subjects With Long-standing Type 2 Diabetes Mellitus (> 10 Years): Evidence From Pooled Data of Randomized, Double-blind, Placebo-controlled, Phase III Trials [J] . Lajara Rosemarie, Aguilar Richard, Hehnke Uwe, Clinical therapeutics . 2014,第11期

机译：利格列汀在长期存在的2型糖尿病（> 10年）受试者中的疗效和安全性：来自随机，双盲，安慰剂对照的III期试验汇总数据的证据
4. Mendelian Randomization of Arsenic Metabolism as a Risk Factor for Hypertensive- and Diabetes-Related Traits among Adults in the Hispanic Community Health Study/Study of Latinos (HCHS/SOL) Cohort [C] . Molly Scannell Bryan, Tamar Sofer, Yasmin Mossavar-Rahmani, Joint annual meeting of the International Society of Exposure Science and the International Society for Environmental Epidemiology . 2018

机译：在西班牙裔社区健康研究/拉丁裔（HCHS / SOL）队列研究中，孟德尔随机将砷代谢作为成人高血压和糖尿病相关性状的危险因素
5. Recruitment, retention and compliance in randomized, phase III clinical trials involving obese patients diagnosed with type 2 Diabetes Mellitus with respect to weight loss practicum report. [D] . Mithani, Moez S. 2012

机译：涉及诊断为2型糖尿病的肥胖患者的有关减肥实践的随机III期临床试验中的招募，保留和依从性报告。
6. Efficacy and Safety of Sitagliptin in Hispanic/Latino Patients with Type 2 Diabetes: A Pooled Analysis from Ten Randomized Placebo-Controlled Phase 3 Clinical Trials [O] . Annaswamy Raji, Jianmin Long, Raymond L. H. Lam, 2018

机译：西他列汀在西班牙裔/拉丁裔2型糖尿病患者中的功效和安全性：十项随机安慰剂对照的3期临床试验的汇总分析
7. Efficacy and Safety of Sitagliptin in Hispanic/Latino Patients with Type 2 Diabetes: A Pooled Analysis from Ten Randomized, Placebo-Controlled Phase 3 Clinical Trials [O] . Annaswamy Raji, Jianmin Long, Raymond L. H. Lam, 2018

机译：SITAGLIPTIN在2型糖尿病患者中SITAGLIPTIN的疗效和安全性：来自10型随机，安慰剂控制第3期临床试验的汇总分析

Efficacy and safety of linagliptin in Hispanic/Latino patients with type 2 diabetes mellitus: a pooled analysis from six randomized placebo-controlled phase 3 trials

摘要

著录项

相似文献

相关主题

期刊订阅